Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA: 600566)

Hubei Jumpcan Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6,523	7,738	4,819	3,819	2,959	2,285
Trading Asset Securities	5,178	3,178	3,045	1,675	1,258	190
Cash & Short-Term Investments	11,701	10,916	7,863	5,494	4,217	2,475
Cash Growth	15.63%	38.82%	43.13%	30.28%	70.40%	55.95%
Accounts Receivable	1,918	2,782	2,850	2,183	2,032	2,055
Other Receivables	16.54	14.99	17.2	11.98	10.33	10.66
Receivables	1,935	2,797	2,867	2,195	2,042	2,065
Inventory	663.7	490.08	391.48	375.59	278.42	338.47
Other Current Assets	49.99	32.5	54.23	58.34	38.13	33
Total Current Assets	14,350	14,235	11,177	8,123	6,576	4,912
Property, Plant & Equipment	2,756	2,922	2,856	3,034	3,141	3,018
Long-Term Investments	-	393.97	332.34	328.44	155.33	106.62
Goodwill	167.3	167.3	167.3	167.3	167.3	167.3
Other Intangible Assets	303.49	305.01	320.62	280.04	283.84	335.83
Long-Term Deferred Tax Assets	32.91	45.45	62.16	57.32	42.62	38.3
Long-Term Deferred Charges	10.82	11.91	3.87	13.19	23.67	4.41
Other Long-Term Assets	530.77	62.16	62.14	127.96	126.51	82.5
Total Assets	18,152	18,144	14,981	12,131	10,516	8,665
Accounts Payable	1,700	2,141	1,505	945.77	452.52	436.09
Accrued Expenses	103.32	246.62	350.39	242.7	207.74	191.44
Short-Term Debt	1,224	1,088	400	-	-	-
Current Portion of Long-Term Debt	-	-	-	627.55	-	-
Current Portion of Leases	1.28	1.06	0.44	1.55	-	-
Current Income Taxes Payable	157.95	182.62	106.09	43.71	69.64	69.39
Current Unearned Revenue	15.91	17.25	49.14	19.34	8.03	15.63
Other Current Liabilities	651.35	915.86	1,016	919.98	1,229	1,127
Total Current Liabilities	3,854	4,592	3,427	2,801	1,967	1,840
Long-Term Debt	-	-	-	-	602.58	576.15
Long-Term Leases	1.22	1.43	0.2	1.02	-	-
Long-Term Unearned Revenue	66.95	71.43	78.19	84.63	90.67	58.29
Long-Term Deferred Tax Liabilities	133.97	109.28	122.05	112.38	90.72	82.97
Other Long-Term Liabilities	0.67	0.82	1.06	1.35	1.67	2.9
Total Liabilities	4,057	4,775	3,629	3,000	2,753	2,560
Common Stock	452.69	452.74	452.74	436.27	436.26	400.24
Additional Paid-In Capital	4,011	3,999	3,984	3,148	3,114	1,766
Retained Earnings	9,716	9,010	6,998	5,431	4,112	3,837
Treasury Stock	-108.37	-111.97	-97.18	-	-	-
Comprehensive Income & Other	-	-	-	100.81	100.87	100.89
Total Common Equity	14,071	13,349	11,337	9,117	7,763	6,104
Minority Interest	23.94	19.42	15.14	14.17	-	-
Shareholders' Equity	14,095	13,369	11,352	9,131	7,763	6,104
Total Liabilities & Equity	18,152	18,144	14,981	12,131	10,516	8,665
Total Debt	1,227	1,090	400.65	630.12	602.58	576.15
Net Cash (Debt)	10,475	9,826	7,463	4,864	3,615	1,899
Net Cash Growth	12.88%	31.67%	53.43%	34.56%	90.37%	83.58%
Net Cash Per Share	11.40	10.72	8.22	5.40	4.33	2.33
Filing Date Shares Outstanding	915.53	921.81	921.82	888.27	888.26	814.82
Total Common Shares Outstanding	915.53	921.81	921.82	888.27	888.26	814.82
Working Capital	10,496	9,644	7,749	5,322	4,609	3,072
Book Value Per Share	15.37	14.48	12.30	10.26	8.74	7.49
Tangible Book Value	13,600	12,877	10,849	8,670	7,312	5,601
Tangible Book Value Per Share	14.86	13.97	11.77	9.76	8.23	6.87
Buildings	-	2,911	2,455	2,473	2,362	1,815
Machinery	-	1,685	1,644	1,566	1,488	1,328
Construction In Progress	-	186.98	352.15	322.17	364.89	725.92

Source: S&P Capital IQ. Standard template. Financial Sources.